References
- Alzheimer's Association. 2022 Alzheimer's disease facts and figures. Alzheimers Dement. 2022;18(4):700-89. https://doi.org/10.1002/alz.v18.4
- Mattson MP. Pathways towards and away from Alzheimer's disease. Nature. 2004;430(7000):631-9. https://doi.org/10.1038/nature02621
- Lane CA, Hardy J, Schott JM. Alzheimer's disease. Eur J Neurol. 2018;25(1):59-70. https://doi.org/10.1111/ene.2018.25.issue-1
- Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry. 1999;66(2):137-47. https://doi.org/10.1136/jnnp.66.2.137
- Bartus RT, Dean RL 3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science. 1982;217(4558):408-14. https://doi.org/10.1126/science.7046051
- Klinkenberg I, Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev. 2010;34(8):1307-50. https://doi.org/10.1016/j.neubiorev.2010.04.001
- Ebert U, Kirch W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Invest. 1998 Nov;28(11):944-9. https://doi.org/10.1046/j.1365-2362.1998.00393.x
- Tang KS. The cellular and molecular processes associated with scopolamine-induced memory deficit: a critical review. Life Sci. 2019;233:116702. https://doi.org/10.1016/j.lfs.2019.116695
- Harrison FE, Hosseini AH, McDonald MP, May JM. Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice. Pharmacol Biochem Behav. 2009 Oct;93(4):443-50. https://doi.org/10.1016/j.pbb.2009.06.006
- Goverdhan P, Sravanthi A, Mamatha T. Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress. Int J Alzheimers Dis. 2012;2012:974013. https://doi.org/10.1155/2012/974013
- Taguchi H, Yosioka I, Yamasaki K, Kim I. Studies on the constituents of Gastrodia elata BLUME. Chem Pharm Bull. 1981;29:55-62. https://doi.org/10.1248/cpb.29.55
- Kim HN, Kim YR, Kim HN, et al. The verify of memory improvement by Gastrodia elata Blume depends on the amount. J Oriental Neuropsychiatry. 2014;25(3):243-52. https://doi.org/10.7231/jon.2014.25.3.243
- Huang GB, Zhao T, Muna SS, et al. Therapeutic potential of Gastrodia elata Blume for the treatment of Alzheimer's disease. Neural Regen Res. 2013;8(12):1061-70.
- Park YM, Lee B, Kim YJ, et al. Prolonged oral administration of Gastrodia elata extract improves learning and memory deficits and reduces neuronal cell death in rats. Lab Anim Res. 2015;31(2):69-77. https://doi.org/10.5625/lar.2015.31.2.69
- Ahn EK, Jeon HJ, Lim EJ, Jung HJ, Park EH. Antiinflammatory and anti-angiogenic activities of Gastrodia elata Blume. J Ethnopharmacol. 2007;110(3):476-82. https://doi.org/10.1016/j.jep.2006.10.006
- Dai JN, Zong Y, Zhong LM, et al. Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS One. 2011;6(7):e21891. https://doi.org/10.1371/journal.pone.0021891
- Ma CL, Ma XM, Wang JJ, et al. Neuroprotective effect of gastrodin in methamphetamine-induced apoptosis through regulating cAMP/PKA/CREB pathway in cortical neurons. Hum Exp Toxicol. 2020 Aug;39(8):1118-29. https://doi.org/10.1177/0960327120911438
- Dai Y, Zhang H, Zhang J, et al. Gastrodin, a promising natural small molecule for the treatment of central nervous system disorders. Int J Mol Sci. 2024 Sep 2;25(17):9540. https://doi.org/10.3390/ijms25179540
- Wu CR, Hsieh MT, Huang SC, Peng WH, Chang YS, Chen CF. Effects of Gastrodia elata and its active constituents on scopolamine-induced amnesia in rats. Planta Med. 1996 Aug;62(4):317-21. https://doi.org/10.1055/s-2006-957892
- Hsieh MT, Wu CR, Chen CF. Gastrodin and p-hydroxybenzyl alcohol facilitate memory consolidation and retrieval, but not acquisition, on the passive avoidance task in rats. J Ethnopharmacol. 1997 Mar;56(1):45-54. https://doi.org/10.1016/S0378-8741(96)01501-2
- Kwon KB, Kim HR, Kim YS, Park EH, Kang HW, Ryu DG. Protective effect of Gastrodae Rhizoma extracts on the LPS-induced cognitive impairment model. J Oriental Neuropsychiatry. 2022;33(3):277-85.
- Thoenen H. Neurotrophins and activity-dependent plasticity. Prog Brain Res. 2000;128:183-91. https://doi.org/10.1016/S0079-6123(00)28016-3
- Schinder AF, Poo MM. The neurotrophin hypothesis for synaptic plasticity and learning. Trends Neurosci. 2000;23(12):639-45. https://doi.org/10.1016/S0166-2236(00)01672-6
- Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME. Ca²⁺ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron. 1998;20(4):709-26. https://doi.org/10.1016/S0896-6273(00)81010-7
- Sakamoto K, Karelina K, Obrietan K. CREB: a multifaceted regulator of neuronal plasticity and protection. J Neurochem. 2011 Jan;116(1):1-9. https://doi.org/10.1111/jnc.2010.116.issue-1
- Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298(5600):1911-12. https://doi.org/10.1126/science.1072682
- Streit WJ, Mrak RE, Griffin WST. Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation. 2004;1:14. https://doi.org/10.1186/1742-2094-1-14
- Fiebich BL, Batista CRA, Saliba SW, Yousif N, de Oliveira ACP. Role of microglia TLRs in neurodegeneration. Front Cell Neurosci. 2018;12:329. https://doi.org/10.3389/fncel.2018.00329
- Qin L, Wu X, Block ML, et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia. 2007;55(5):453-62. https://doi.org/10.1002/glia.v55:5